Company Profile
Xtant Medical Stock Price, News & Analysis
- Ticker:
- XTNT
- Exchange:
- AMEX
- Sector:
- Biopharma
- Location:
- United States
Stock performance
0.44 USD (+2.61%)
Close
Last updated: July 27, 2026
65.2M USD
Market cap
Why the stock is moving
As of Jul 27, 2026, XTNT closed up 2.61% at $0.4399. No new same-company headline was identified in the current news window.
Company overview
Business overview
Xtant Medical is a spinal and biologics medical device company focused on bone grafts, biologics, and reconstructive products. Its business is centered on procedure-linked orthopedic care.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Xtant sits in medtech and regenerative products.
Business Model Characteristics
The company depends on product adoption, surgical demand, and the economics of spinal reconstruction.
Position Within the Biotechnology Landscape
Xtant is outside biotech and belongs to the orthopedic-device and biologics-products layer.
Future catalysts
Xtant Medical’s catalysts are orthopedic biologics, spine product execution, and any margin or portfolio update that improves the business mix. The market cares about steady adoption rather than a single headline.
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Denali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026
DNLI · Source: Denali Therapeutics
- 02
- 03
ICU Medical Announces Time of Second Quarter 2026 Earnings Conference Call
ICUI · Source: ICU Medical
- 04
Encompass Health increases and declares dividend on common stock
EHC · Source: Encompass Health Corporation
- 05
Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026
TCMD · Source: Tactile Systems Technology, Inc.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Xtant Medical (XTNT)?
Xtant Medical (XTNT) most recently closed at 0.44 USD, a +2.61% move versus the previous session.
What is the market cap of Xtant Medical (XTNT)?
Xtant Medical currently has a market capitalization of 65.2M USD on BioPharmSignal.
What does Xtant Medical do?
Xtant Medical is a spinal and biologics medical device company focused on bone grafts, biologics, and reconstructive products. Its business is centered on procedure-linked orthopedic care.
On which exchange is XTNT stock listed?
Xtant Medical (XTNT) is associated with AMEX, United States, Biopharma.
What is Xtant?
Xtant Medical’s catalysts are orthopedic biologics, spine product execution, and any margin or portfolio update that improves the business mix.
Which conditions is Xtant Medical targeting with Xtant?
Xtant Medical’s catalysts are orthopedic biologics, spine product execution, and any margin or portfolio update that improves the business mix.
How does Xtant Medical describe recent progress with Xtant?
Xtant Medical’s catalysts are orthopedic biologics, spine product execution, and any margin or portfolio update that improves the business mix.
What is Medical?
Xtant Medical is a spinal and biologics medical device company focused on bone grafts, biologics, and reconstructive products.